Recognition and prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy
CSTR:
Author:
Affiliation:

(1. First Clinical Medical College, Shanxi Medical University, Taiyuan 030001, China;2. Department of Geriatrics, First Hospital of Shanxi Medical University, Taiyuan 030001, China)

Clc Number:

Fund Project:

This work was supported by the Preference Funding Project for Science and Technology Activities of Returned Overseas Personnel in ShanxiProvince (201991-7).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Hypertrophic cardiomyopathy (HCM) is a hereditary cardiomyopathy. Most HCM patients develop mild symptoms throughout their lives. However, they also are at risk of ventricular arrhythmia and sudden cardiac death (SCD), with a prevalence of 80/100000 in Chinese adults, and SCD is the most serious complication. Identifying the risk of SCD in HCM patients can improve their prognosis outcome. In this article, based on the current guidelines and recent studies on HCM and SCD, we review the pathological mechanism, identification of risk factors and prevention of SCD in HCM patients.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:November 30,2020
  • Revised:
  • Adopted:
  • Online: November 29,2021
  • Published:
Article QR Code